Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: May 2011

Case 13 - A lady with weakness, fasciculations, and failing memory

Summary

This chapter presents the case of a 72-year-old man with a 10-year history of Parkinson's disease. He experienced visual hallucinations with preserved insight 2 years previously, subsiding on withdrawal of selegiline. Physical examination revealed a fairly symmetric and moderately severe parkinsonian syndrome, with akinetic-rigid features dominant and little in the way of rest tremor. The initial diagnostic impression was of a dementia syndrome relating to his Parkinson's disease, although the doctor was initially uncomfortable with what he regarded as a normal mini-mental state examination (MMSE) score of 27 out of 30. After 3 and 6 months, repeat MMSE scores were 23 and 25, respectively. Despite some initial diagnostic uncertainty, the patient was commenced on a cholinesterase inhibitor with considerable improvement in his psychotic features and lessening of his periods of confusion. Rationalization of anti-parkinsonian and other medications is an important first step in the management of PD-D.

References and further reading

AyalaYM, PantanoS, D'AmbrogioA, et al. (2005). Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function. J Mol Biol, 348, 575–88.
BrooksBR, MillerRG, SwashM, MunsatTL (2000). El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord, 1, 293–9.
ChaudhuriKR, CrumpS, al-SarrajS, AndersonV, CavanaghJ, LeighPN (1995). The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study. J Neurol Sci, 129, Suppl:11–12.
FormanMS, TrojanowskiJQ, LeeVM (2007). TDP-43: a novel neurodegenerative proteinopathy. Curr Opin Neurobiol, 17, 548–55.
Lomen-HoerthC (2004). Characterization of amyotrophic lateral sclerosis and frontotemporal dementia. Dement Geriatr Cogn Disord, 17, 337–41.
Lund & Manchester groups (1994). Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry, 57, 416–18.
MackenzieIR (2007). The neuropathology of FTD associated With ALS. Alzheimer Dis Assoc Disord, 21, S44–9.
MackenzieIR, NeumannM, BigioEH, et al. (2009). Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 117, 15–18.
McKhannGM, AlbertMS, GrossmanM, MillerB, DicksonD, TrojanowskiJQ (2001). Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol, 58, 1803–9.
NearyD, SnowdenJ, MannD (2005). Frontotemporal dementia. Lancet Neurol, 4, 771–80.
NearyD, SnowdenJS, GustafsonL, et al. (1998). Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 51, 1546–54.
NeumannM, SampathuDM, KwongLK (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130–3.
OlneyRK, MurphyJ, ForshewD, et al. (2005). The effects of executive and behavioral dysfunction on the course of ALS. Neurology, 65, 1774–7.
RingholzGM, AppelSH, BradshawM, CookeNA, MosnikDM, SchulzPE (2005). Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology, 65, 586–90.
StrongMJ (2008). The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler, 9, 323–38.
WangHY, WangIF, BoseJ, ShenCK (2004). Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics, 83, 130–9.